International Clinical Trial: A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07453004) titled 'A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: TJ Biopharma Co., Ltd.

Condition: Acute Gouty Arthritis

Intervention: Drug: Plonmarlimab Drug: Compound betamethasone Drug: Plonmarlimab placebo

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: Ap...